Can anything shut down the Gold rally?
Norman L. Wright, a director at Option Care Health, Inc. (NASDAQ:OPCH), acquired 3,411 shares of common stock on September 9, 2025, in a transaction valued at $99,976. The purchases were executed at prices ranging from $29.28 to $29.31 per share. This insider purchase aligns with broader management confidence in the $4.7 billion market cap company, which currently maintains a "GREAT" financial health score according to InvestingPro analysis.
Following the transaction, Wright directly owns 15,501 shares of Option Care Health. With analysts setting price targets between $34 and $41, and the company showing strong revenue growth of 17% over the last twelve months, this insider buying could signal management’s positive outlook. InvestingPro subscribers can access 8 additional key insights about Option Care Health, including detailed valuation metrics and growth forecasts.
In other recent news, Option Care Health reported its second-quarter earnings for 2025, surpassing Wall Street expectations. The company achieved earnings per share of $0.41, which exceeded the forecasted $0.38. Additionally, Option Care Health’s revenue reached $1.42 billion, marking a 15% year-over-year growth and surpassing both JMP Securities’ estimate of $1.33 billion and the consensus forecast of $1.35 billion. Following these results, JMP Securities raised its price target for the company from $36.00 to $38.00, while maintaining a Market Outperform rating. These developments indicate a positive performance for Option Care Health in the recent quarter.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.